Baseline characteristics of patients
| Characteristic . | MPT (n = 182) . | MP (n = 175) . |
|---|---|---|
| Age, y | ||
| Median | 74.6 | 74.1 |
| Younger than 65, no. (%) | 3 (2) | 3 (2) |
| 65-69, no. (%) | 34 (19) | 36 (21) |
| 70-74, no. (%) | 62 (34) | 56 (32) |
| 75-79, no. (%) | 45 (25) | 38 (22) |
| Older than 79, no. (%) | 38 (21) | 42 (24) |
| Male sex, % | 51 | 61 |
| Durie-Salmon stage, % | ||
| I | 12 | 18 |
| II | 41 | 31 |
| III | 43 | 46 |
| Missing | 4 | 5 |
| ISS stage, % | ||
| 1 | 13 | 18 |
| 2 | 37 | 43 |
| 3 | 36 | 30 |
| Missing | 14 | 9 |
| WHO performance status, % | ||
| 0-2 | 67 | 65 |
| 3-4 | 27 | 33 |
| Missing | 5 | 3 |
| Median β2-microglobulin, mg/L (25%-75% range) | 4.5 (3.1-8.8) | 4.2 (3.1-6.4) |
| Median hemoglobin, g/dL (25%-75% range) | 10.3 (9.3-11.8) | 10.8 (9.7-11.8) |
| Median creatinine, μM (25%-75% range) | 95 (77-131) | 94 (79-135) |
| Median calcium, mM (25%-75% range) | 2.5 (2.4-2.7) | 2.5 (2.4-2.6) |
| Characteristic . | MPT (n = 182) . | MP (n = 175) . |
|---|---|---|
| Age, y | ||
| Median | 74.6 | 74.1 |
| Younger than 65, no. (%) | 3 (2) | 3 (2) |
| 65-69, no. (%) | 34 (19) | 36 (21) |
| 70-74, no. (%) | 62 (34) | 56 (32) |
| 75-79, no. (%) | 45 (25) | 38 (22) |
| Older than 79, no. (%) | 38 (21) | 42 (24) |
| Male sex, % | 51 | 61 |
| Durie-Salmon stage, % | ||
| I | 12 | 18 |
| II | 41 | 31 |
| III | 43 | 46 |
| Missing | 4 | 5 |
| ISS stage, % | ||
| 1 | 13 | 18 |
| 2 | 37 | 43 |
| 3 | 36 | 30 |
| Missing | 14 | 9 |
| WHO performance status, % | ||
| 0-2 | 67 | 65 |
| 3-4 | 27 | 33 |
| Missing | 5 | 3 |
| Median β2-microglobulin, mg/L (25%-75% range) | 4.5 (3.1-8.8) | 4.2 (3.1-6.4) |
| Median hemoglobin, g/dL (25%-75% range) | 10.3 (9.3-11.8) | 10.8 (9.7-11.8) |
| Median creatinine, μM (25%-75% range) | 95 (77-131) | 94 (79-135) |
| Median calcium, mM (25%-75% range) | 2.5 (2.4-2.7) | 2.5 (2.4-2.6) |